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Summary 26 
Controlling the spread of Johne’s disease, caused by Mycobacterium avium subsp. 27 
paratuberculosis (MAP), in domestic livestock is challenging. Current diagnostic methods 28 
lack sufficient sensitivity to detect sub-clinically infected animals, and thus better diagnostic 29 
methods are needed. This study was carried out to investigate the diagnostic potential of two 30 
novel peptide-mediated magnetic separation (PMS)-based tests - a PMS-phage assay and 31 
PMS-culture – both of which have been developed and optimised to detect viable MAP cells 32 
in bovine milk. Individual milk samples (50 ml) were obtained from 105 ‘non-infected’ and 40 33 
‘MAP-infected’ animals (classified as such on the basis of prior faecal culture and serum-34 
ELISA results) in three dairy herds, and tested in parallel by the PMS-phage assay and 35 
PMS-culture. Diagnostic sensitivity (DSe) and specificity (DSp) of the PMS-phage and PMS-36 
culture methods were determined relative to the MAP infection status of the animal 37 
contributing the milk sample.  The PMS-based tests applied individually showed moderate 38 
DSe (PMS-culture 0.250 and PMS-phage assay 0.325) and high DSp (0.962 and 1.000, 39 
respectively). When results of the two PMS-based tests were combined, DSe increased 40 
substantially to 0.525 and the DSp was calculated to be 0.962. It was concluded that 41 
combined application of the PMS-phage assay and PMS-culture provided the most complete 42 
picture regarding the presence of viable MAP in bovine milk samples. A comprehensive 43 
validation of the PMS-based assays relative to currently used diagnostic methods (faecal 44 
culture and serum-ELISA) would be the next step in assessment of the diagnostic potential 45 
of these novel PMS-based methods.   46 
 47 
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Introduction 54 
 55 
Liquid and solid culture is still widely considered the ‘gold standard’ method for the detection 56 
of viable MAP in milk and faeces for the diagnosis of Johne’s disease (Slana et al., 2008, 57 
Britton et al., 2016). However, due to the lack of a selective culture medium and the long 58 
incubation times required for the growth of MAP, contamination of cultures is common. 59 
Decontamination protocols are routinely employed prior to culture, however these can affect 60 
MAP viability resulting in non-isolation of some, or all, of the MAP present (Dundee et al. 61 
2001, Bradner et al. 2013). Due to the problems associated with culturing MAP and the long 62 
waiting time for test results, MAP culture is an imperfect ‘gold standard’ for the detection of 63 
viable MAP.  Other commonly used MAP diagnostic tools include ELISA-based methods, 64 
which have been extensively applied for the assessment of Johne’s prevalence within herds 65 
(Slana et al., 2008). While ELISA methods are rapid, inexpensive and often highly specific, 66 
they are based on the detection of anti-MAP antibodies rather than viable MAP cells, so such 67 
tests identify whether an animal has sero-converted but do not necessarily confirm MAP 68 
infection. Thus, ELISA tests often possess low detection sensitivity (Lavers et al., 2014). The 69 
specificity of the serum-ELISA test may also be sub-optimal due to cross-reactivity with 70 
antibody responses to other environmental Mycobacterium spp. (Nielsen and Toft, 2008) or 71 
Mycobacterium bovis (Lilenbaum et al. 2007), depending on geographic circumstances  72 
There is an urgent need for a rapid detection method for MAP which is both specific 73 
and sensitive, and which can distinguish between viable and non-viable cells. The recently 74 
developed Peptide-mediated magnetic separation (PMS)-phage assay, and/or PMS-culture, 75 
may represent such tests.  Potentially, PMS could replace chemical decontamination prior to 76 
culture, thus avoiding deleterious effects on MAP viability that impair the analytical sensitivity 77 
of existing culture methods. The PMS-phage assay could speed-up the identification of MAP 78 
infected animals which are transmitting the infection through MAP-contaminated milk, which 79 
is key to limiting the spread of Johne’s disease.  Therefore, improvements in the sensitivity of 80 
MAP diagnostics would have a huge impact on the control of Johne’s disease.  81 
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The PMS-based methods employ paramagnetic beads coated with MAP-specific 82 
biotinylated aMp3 and aMptD peptides (Foddai et al. 2010) to selectively capture and 83 
concentrate low numbers of MAP cells from milk samples.  The analytical specificity of the 84 
PMS assay applied to milk was previously determined to be >98%, with an analytical 85 
sensitivity for the PMS-phage and PMS-culture assays of 10-102 pfu/ml and 102-103 cfu/ml, 86 
respectively (O’Brien et al., 2016).  These methods have principally been developed and 87 
optimised for detection of MAP in milk. Whilst the PMS-phage assay has been applied to 88 
faeces previously (Foddai et al. 2011), higher numbers of false positive plaques are generally 89 
encountered when testing faeces because the D29 phage involved can also infect various 90 
environmental Mycobacterium spp. (Rybniker et al. 2006) that may occur in that sample 91 
matrix.   Also, given the higher background microflora of bovine faeces compared to milk, 92 
PMS alone prior to culture (without application of some form of mild chemical 93 
decontamination) is unlikely to be as successful when testing bovine faeces.  94 
The present study was carried out to assess the diagnostic potential of the two PMS-95 
based assays by testing milk samples from individual animals of known MAP infection status.  96 
Their diagnostic potential was assessed by determining diagnostic sensitivity (DSe), the 97 
proportion of animals with evidence of infection that test positive by the novel assay(s), and 98 
diagnostic specificity (DSp), the number of animals without evidence of infection that test 99 
negative by the novel assay(s). This study was not a validation study because the ‘gold 100 
standard’ tests (faecal culture and serum-ELISA) could not be carried out 101 
contemporaneously with the PMS-based tests for financial and logistical reasons.  102 
 103 
Materials and Methods 104 
 105 
Acquisition of milk samples 106 
Milk samples were obtained from selected animals in three Northern Ireland dairy herds (A, B 107 
and C), for which previous faecal culture and serum-ELISA results were available to permit 108 
them to be categorised as ‘MAP-infected’ or ‘non-infected for milk collection purposes. Herds 109 
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A and B were MAP infected dairy herds with test (faecal culture and/or serum ELISA) 110 
positive animals present, and both had a history of clinical Johne’s cases.  Herd C was a 111 
closed herd that had never had a known or suspected case of Johne’s disease.  In addition, 112 
all animals in the herd have consistently tested negative for MAP infection by faecal culture 113 
and ELISA in previous years.  Animals in Herds A and B were deemed to be ‘MAP infected’ if 114 
they had tested positive by faecal culture (using TREK automated ESPII liquid culture 115 
system) and/or serum-ELISA (IDEXX ELISA) when screened as part of the Department of 116 
Agriculture, Food and the Marine Food Institutional Research Measure-funded ICONMAP 117 
project in 2013.  ‘Non-infected’ animals were those animals in Herd C that tested negative by 118 
both tests in 2013.   119 
     A total of 145 individual 50 ml milk samples (105 from ‘non-infected’ animals from Herd C 120 
and 40 from ‘MAP infected’ animals in Herds A and B) were obtained from individual cows for 121 
testing by the PMS-phage assay and PMS-culture.  It was hoped that the majority of milk 122 
samples from ‘MAP infected’ cows would be sourced from animals positive by both faecal 123 
culture and serum-ELISA tests. However, due to the time lapse between blood and faecal 124 
testing in 2013 (no more recent MAP testing had been carried out) and milk sample 125 
collection between December 2015 and January 2016, many of the animals in this category 126 
had been culled from MAP infected herds A and B and were no longer available for milk 127 
sampling. In consequence, milk samples were mainly collected from infected animals 128 
positive by one or other of the diagnostic tests (nine  positive by serum-ELISA only and 24 129 
positive by faecal culture only) rather than both tests (n=7). The 105 milk samples from ‘non-130 
infected’ cows were exclusively sourced from cows in the Johne’s disease negative Herd C.  131 
All milk samples were collected by a veterinarian during the early morning milking 132 
session on each farm.  The vet was instructed to dip the teat of each animal in chlorhexidine 133 
and use an alcohol wipe to remove all visible dirt and faeces before milking each animal by 134 
hand into a pre-labelled sterile 50 ml centrifuge tube. Once collected, the milk samples were 135 
placed in a cool box with ice packs and kept at 4°C during transportation to the laboratory at 136 
Queen’s University Belfast (QUB). Unless testing was to begin immediately, the milk samples 137 
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were stored at -80°C until required; as a previous study at QUB had found that MAP viability 138 
was not compromised if milk was stored for up to 4 weeks at -80°C (Foddai and Grant, 139 
2015).  140 
 141 
Preparation of culture media 142 
Broth for PMS-culture was prepared using Middlebrook 7H9 broth (Difco), prepared 143 
according to the manufacturer’s instructions, supplemented with 10 % (v/v) OADC (Difco) 144 
and 2 µg/ml mycobactin J (Synbiotics Europe SAS, Lyon, France) and PANTA (Polymyxin B 145 
40,000 IU/l, Amphotericin B 4,000µg/l, Nalidixic acid 16,000 µg/l, Trimethoprim 4,000µg/l, 146 
and Azlocillin 4,000µg/l; Becton Dickinson, Oxford, UK). The autoclaved and supplemented 147 
7H9 broth was dispensed in 5 ml volumes into 15 ml pre-sterilised screw-cap glass tubes 148 
that had not previously been used for MAP culture.  149 
Herrold’s egg yolk medium (HEYM) was prepared in-house using 9 g bacteriological 150 
peptone (Difco), 4.5 g NaCl, 15 g bacteriological agar, 2.7 g beef extract, 4.7 g sodium 151 
pyruvate and 27 ml glycerol (all from Sigma-Aldrich, Poole, UK), prepared in 900 ml water. 152 
After autoclaving at 121°C for 15 min and cooling to ~55°C the medium was supplemented 153 
with 2 µg/ml of Mycobactin J (Synbiotics Europe SAS), 5 ml of 2% (w/v) malachite green 154 
(Sigma-Aldrich) and 100 ml (v/v) sterile egg yolk (prepared in-house), before dispensing 5 ml 155 
volumes into 15 ml pre-sterilised screw-cap glass tubes that had not previously been used 156 
for MAP culture. The tubes were supported at an angle to allow the medium to solidify 157 
forming HEYM slopes. Both culture media were stored at 4°C until required.  158 
 159 
Peptide-mediated magnetic separation (PMS)-based tests  160 
The optimised milk testing procedure, described in detail previously by Foddai and Grant 161 
(2015), was adopted during this study. Frozen milk samples were thawed overnight at 4oC 162 
and brought to room temperature for at least an hour before centrifugation at 3,000 g for 15 163 
min in a Rotina 380 centrifuge (Hettich, Germany). The milk fat and supernatant were 164 
discarded and the pellet re-suspended in 1 ml PBS pH 7.4 buffer containing 0.05 % (v/v) 165 
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Tween 20 (PBST). The samples were then ultrasonicated (pulse mode 37 kHz for 4 min in 166 
ice-water) in the Ultrasonic PH 30 bath (Fisher Scientific Ltd) to break up any MAP clumps, 167 
before automated magnetic separation was performed with 10 µl (5 µl of each coated bead) 168 
of MyOne™ Tosylactivated® Dynabeads coated with biotinylated aMp3 and aMptD synthetic 169 
peptides (coated in-house as described elsewhere, Foddai et al. 2010) using a Dynal 170 
BeadRetriever (Invitrogen) and the pre-loaded ’Environmental’ programme. This programme 171 
consisted of a capture step for 30 min with constant mixing, two wash steps in 1 ml PBST for 172 
1 min with mixing, and final resuspension of the beads in 1 ml 7H9 broth supplemented with 173 
10% (v/v) OADC, 2 mM CaCl2 and NOA antibiotic supplement (Nystatin 50,000 IU/l, Oxacillin 174 
2 mg/l and Aztreonam 30 mg/l; Abtek Biologicals Ltd, Liverpool, UK). Sterile PBST was used 175 
as a negative PMS control and a pure MAP cell suspension diluted in PBST as a positive 176 
PMS control. Both controls were processed through the PMS-phage and PMS-culture assays 177 
with each batch of test samples.   178 
 PMS-culture and confirmation of suspect positive cultures was carried out as follows:  179 
of the 1 ml bead suspensions after PMS, 100 µl was inoculated into supplemented 7H9 broth 180 
(described above) and 100 µl was spread onto HEYM agar slopes (described above). The 181 
remaining 800 µl of bead suspension was processed through the phage amplification assay 182 
(described below). The broth and HEYM slope PMS-cultures were incubated at 37°C and 183 
absorbance measurements of the broths at OD600nm (measured using Biowave CO8000 184 
Density meter, Biochrom Ltd., Cambridge, UK) were recorded periodically, as a measure of 185 
microbial growth over time. Slopes were examined periodically for evidence of typical MAP 186 
colonies.  187 
 Standard Ziehl-Neelsen (ZN) staining was used to determine if acid-fast bacteria were 188 
present in PMS-culture broths showing an increase in OD600 nm and in suspect colonies from 189 
HEYM slopes. For broth cultures, 1 ml of broth was centrifuged for 10 min at 16,000 g 190 
(Eppendorf 5424R). The supernatant was discarded and the pellet washed in 100 µl of 191 
molecular grade water. The pellet was resuspended in 50 µl of molecular grade water. For 192 
HEYM slopes the suspect MAP colonies were removed using a sterile loop and suspended 193 
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in 50 µl molecular grade water. Twenty microlitres of either sample was transferred onto 194 
microscope slides and heat-fixed before ZN staining. The slides were examined under oil 195 
immersion at 100x magnification.  196 
The remainder of the 50 µl cell suspension from suspect MAP positive broths or 197 
colonies was transferred to thin-walled PCR tubes and heated to 95°C for 25 min to lyse cells 198 
and release DNA. The samples were centrifuged briefly to pellet cell debris before 5 µl of the 199 
supernatant was added to 45 µl of PCR master mix containing 1X Green buffer, 3 mM MgCl2, 200 
200 µM of each dNTP, 1 U Platinum Taq (all from Invitrogen) and 20 pmol of P90 201 
5’GTTCGGGGCCGTCGCTTAGG’3 and P91 5’GAGGTCGATCGCCCAC GTGA’3 (Moss et 202 
al. 1992). The PCR cycling conditions were: 94°C for 2 min, 33 cycles of 94°C for 1 min, 203 
62°C for 1 min, 72°C for 3 min, final extension was 72°C for 10 min before holding at 4°C. 204 
The PCR products were visualised by agarose gel electrophoresis and the expected PCR 205 
product size was 394 bp. 206 
 The PMS-phage assay was carried out essentially as described by Foddai et al. 207 
(2011).  After PMS of the milk samples, 800 µl of each bead suspension (in 7H9 broth 208 
supplemented with 10 % (v/v) OADC, 2 mM CaCl2 and NOA antibiotic supplement) was 209 
processed through the phage amplification assay. Briefly, 100 µl of D29 phage solution 210 
(containing approximately 108 pfu) was added to each 800 µl sample and incubated for 2 211 
hours at 37°C after which time 100 µl of freshly prepared 100 mM ferrous ammonium 212 
sulphate (FAS) solution was added to each sample. The samples were mixed to ensure that 213 
all of the internal surfaces of the vial were coated before being left to stand at room 214 
temperature for 5 min. The samples were then vortexed and allowed to stand for a further 5 215 
min before neutralising the sample by adding 5 ml of 7H9 broth containing 10% (v/v) OADC 216 
and 2 mM CaCl2. The samples were incubated at 37oC until a total of 3.5 h had elapsed 217 
since addition of D29 phages, after which the samples were transferred to Petri dishes 218 
containing 1 ml (~108 cfu/ml) Mycobacterium smegmatis mc2 155 sensor cells and 5 ml 219 
molten 7H9 agar. After gentle swirling to mix the plate contents, the plates were allowed to 220 
solidify before incubation at 37°C overnight.  The following morning, any plaques present 221 
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were counted and numbers recorded. A negative phage assay control (7H9 broth only) was 222 
included with each set of samples processed to ensure the efficacy of the FAS treatment to 223 
inactivate the seed D29 phage. 224 
 To confirm that the plaques observed were due to the presence of viable MAP in the 225 
original milk sample, and not arising from other Mycobacterium spp. or non-inactivated D29 226 
phages, an IS900-based Plaque-PCR (Swift et al. 2014) was performed on DNA extracted 227 
from the plaques. Up to a maximum of 10 plaques per sample were selected for DNA 228 
extraction from each PMS-phage assay positive sample. The centre of each plaque was 229 
excised using a sterile loop and transferred to an Eppendorf tube. The DNA was extracted 230 
from the plaque using the Zymoclean™ Gel DNA Recovery kit (Cambridge Bioscience, UK), 231 
according to the manufacturer’s instructions. DNA was eluted from the Zymoclean columns 232 
using 20 µl elution buffer (supplied with kit) or molecular grade water. DNA was stored at -233 
20°C until required for plaque PCR.  A protocol modified from Whittington et al. (1998) was 234 
used to target the IS900 insertion element. To 40 µl of master mix containing 1 X DreamTaq 235 
Green Buffer, 2.5 mM MgCl2, 200 µM of each dNTP, 1 U DreamTaq DNA polymerase 236 
(Thermo Fisher Scientific) and 250 ng of P90 5’GAAGGGTGTTCGGGGCCGTCGCTTAGG’3 237 
and P91 5’GGCGTTGAGGTCGATCGCCC ACGTGAC’3 primers (Whittington et al. 1998), 238 
10 µl of plaque DNA was added. The PCR cycling conditions were: 94°C for 5 min, 37 cycles 239 
of 94°C for 30 sec, 62°C for 30 sec and 72°C for 1 min, final extension at 72°C for 4 min, and 240 
then sample cooled to 4°C. Agarose gel electrophoresis was used to visualise the PCR 241 
products and TrackIt™ 100 bp DNA ladder (Invitrogen) was loaded alongside the PCR 242 
products. The expected IS900 PCR product size was 400 bp. 243 
 244 
Statistical analysis of results 245 
Statistical analysis was performed to compare PMS-phage and PMS-culture results with 246 
infection status of the animal supplying the milk samples (assigned on the basis of most 247 
recent faecal culture and serum-ELISA results). Kappa agreement was calculated between 248 
PMS-phage assay and PMS-culture results, and between results of these tests and the 249 
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animal’s infection status, and Fisher’s Exact Test was performed to obtain estimates of the 250 
DSp and DSe of the PMS-phage assay, PMS-culture, and the combined PMS-based 251 
methods, using GraphPad InStat (GraphPad Software Inc., La Jolla, CA, USA).  252 
 253 
Results 254 
 255 
Performance of PMS-phage and PMS-culture assays 256 
 A total of 145 milk samples from individual cattle were processed through the PMS-phage 257 
assay and PMS-culture. Positive and negative control samples reported correctly throughout 258 
the study; MAP B4 and ATCC 19698 broths were positive by the PMS-phage assay, 259 
producing between 30-300 plaques which confirmed positive by IS900 Plaque-PCR, and 260 
sterile broth was negative by the PMS-phage assay with no plaques observed. Only those 261 
milk samples yielding plaques that were confirmed to be MAP positive by Plaque PCR were 262 
deemed to be positive by the PMS-phage assay when results were statistically analysed. All 263 
Herd C (MAP negative herd) milk samples tested negative by the PMS-phage assay. The 264 
mean plaque counts for PMS-phage assay positive milk samples from Herd A and Herd B 265 
(two MAP infected herds) were 94.9 pfu/50 ml and 8.0 pfu/50 ml, respectively (Table 1).  Of 266 
the 145 milk samples tested, 21 (14.5%) produced plaques by the PMS-phage assay, of 267 
which 12 (8.3%) were confirmed to be MAP positive by Plaque IS900 PCR (Table 1).  One 268 
milk sample (Herd A, milk sample 10 in Table 1) yielded just three plaques that tested 269 
negative by IS900 Plaque-PCR, so the PMS-phage assay result was recorded as negative, 270 
but this sample subsequently tested PMS-culture positive.  This Plaque-PCR result is likely 271 
to represent a false negative PMS-phage assay result, perhaps due to the presence of a low 272 
quantity of DNA being retrieved from just three plaques.  273 
All MAP positive controls from the PMS-culture assay produced acid-fast positive broth 274 
cultures, and suspect colonies that were confirmed to be MAP by IS900 PCR. The negative 275 
(sterile broth) controls did not demonstrate any evidence of acid-fast cells in broth cultures or 276 
suspect colonies on HEYM slopes.  PMS-culture was positive for 14 (9.7%) samples, i.e. 277 
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suspect colonies or broths confirmed by IS900 PCR (Figure 1). Of the total number of PMS-278 
phage assay and PMS-culture positives (n=25), only 2 (8.0%) samples were positive by both 279 
PMS tests (Figure 1). When the results of the PMS-phage and PMS-culture assays were 280 
analysed, Kappa agreement (± standard error) between the two tests was deemed to be 281 
‘poor’ (0.061 ±0.099). The two tests, although detecting similar numbers of MAP positive milk 282 
samples, were seemingly detecting different subsets of infected animals.   283 
 284 
Diagnostic potential of PMS-phage and PMS-culture assays  285 
The ability of the PMS-phage, PMS-culture, and combined PMS-phage-culture assays to 286 
correctly identify ‘MAP infected’ and ‘non-infected’ animals from Northern Ireland dairy herds 287 
was assessed. The infection status of each animal from which milk was obtained had been 288 
assigned on the basis of a positive faecal culture and/or a positive serum-ELISA result at the 289 
time of last MAP testing, which was in 2013. Contingency tables (2x2) of results were 290 
constructed separately for PMS-phage assay and PMS-culture, and also for the combined 291 
PMS-based tests (Table 2).  Of the 40 MAP ‘infected’ animals, the PMS-phage assay 292 
identified 13 (32.5%) animals shedding viable MAP in milk which was deemed to be 293 
‘moderate’ agreement, with a corresponding Kappa value (± standard error) of 0.411 ± 0.083 294 
(Table 2). The DSp of the PMS-phage assay was calculated to be 1.000 and DSe to be 295 
0.325 (Table 2). In contrast, the PMS-culture assay was found to have ‘fair’ agreement with 296 
animal infection status (Kappa value ± standard error of 0.265 ± 0.084). PMS-culture 297 
detected viable MAP in the milk of 10 (25%) of 40 ‘MAP infected’ animals, thereby 298 
demonstrating a DSe of 0.250 (Table 3). Diagnostic specificity (DSp) of PMS-culture was 299 
0.962 because 4 (3.8%) of 105 animals categorised as ‘non-infected’ animals tested positive 300 
for viable MAP by this test.  When results of the PMS-phage and PMS-culture assays were 301 
combined, the agreement with animal infection status was ‘moderate’ with a Kappa value of 302 
0.551 ± 0.080, which was greater agreement than either test individually. Just over half of 303 
the ‘MAP infected’ animals were correctly identified when the assays were combined, 304 
increasing DSe to 0.525; which is much higher than for either the PMS-phage assay (0.325) 305 
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or PMS-culture (0.250) applied separately (Table 2). Diagnostic specificity of the combined 306 
PMS-based tests remained high at 0.962.  307 
 308 
Discussion 309 
The accurate identification of cattle shedding viable MAP in their milk is crucial to preventing 310 
transmission of Johne’s disease between cows and calves. Detection of viable MAP in cows’ 311 
milk more generally is also of interest from a public health-food safety perspective. The 312 
objective of this study was to evaluate the diagnostic potential of two novel PMS-based 313 
assays, specifically as tests to detect infected animals shedding viable MAP in their milk. 314 
Previously published studies have detected 10-103 MAP/50 ml milk by decontamination and 315 
culture (Sweeney et al., 1992, Giese and Ahrens, 2000, Ayele et al., 2005) and 102-104 316 
MAP/50 ml milk by qPCR (Slana et al., 2008) or IS900 PCR (Stabel et al., 2014).  The PMS-317 
phage assay and PMS-culture have sufficient analytical sensitivity (10-102 pfu/ml and 102-103 318 
cfu/ml, respectively; O’Brien et al., 2016) to be able to detect these low numbers of MAP in 319 
cow’s milk. However, it is documented that MAP shedding into milk can be intermittent 320 
(Fecteau and Whitlock, 2010), and the number of MAP shed can vary by stage of infection, 321 
with clinical animals shedding higher numbers of MAP in their milk than sub-clinical animals 322 
(Sweeney et al., 1992, Stabel et al., 2014).  Stage of lactation and season are also influential 323 
factors in the accurate diagnosis of Johne’s disease.  For example, MAP shedding primarily 324 
occurs during early lactation (Nielson and Toft, 2012, Zervens et al., 2013, Stabel et al., 325 
2014), and spring and summer are thought to be the seasons which offer the greatest 326 
chance of identifying MAP infected animals (Wolf et al., 2015). Milk samples tested during 327 
this study were collected between November 2015 and January 2016, which may have 328 
negatively impacted the number of MAP positive samples detected.  It should also be noted 329 
that the number of MAP shed directly into milk within the udder of infected animals can also 330 
be significantly augmented by faecal contamination during the milking process (Vissers et al. 331 
2007). Whilst teat cleaning was carried out by the vet prior to collection of a milk sample from 332 
each animal during this study, the efficacy or consistency of this decontamination step 333 
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cannot be guaranteed. Consequently, some of the MAP contamination of milk detected 334 
during this study may have originated from faeces of infected animals rather than due to 335 
direct shedding of MAP into milk within the udder. Irrespective of the potential source of MAP 336 
in milk, a method to accurately detect the presence of viable MAP in milk is urgently required.  337 
During this study, a total of 145 milk samples from ‘MAP infected’ (n=40) and ‘non-338 
infected’ dairy cows (n=105) were tested by both the PMS-phage assay and PMS-culture.  339 
Overall, there was ‘poor’ agreement between results of the two PMS-based tests (Kappa ± 340 
SE of 0.061 ± 0.099). Approximately equal numbers of animals, but different subsets of 341 
animals, tested positive for viable MAP by the two PMS-based tests (Figure 1), which was an 342 
unexpected finding.  There are a couple of possible explanations. Firstly, MAP cells present 343 
in raw milk may exist in different metabolic states (viable, viable but non culturable, dormant, 344 
dead), and this will have influenced MAP cell infectivity by the D29 phage (Swift et al., 2014). 345 
The PMS-phage assay will only detect MAP cells that are fully viable at the point of testing, 346 
since the D29 phage needs to ‘hijack’ the MAP cell in order to replicate itself. If the phage is 347 
unable to replicate, then the MAP cell will not burst and release D29 phages to initiate plaque 348 
formation in the plaque assay and false negative PMS-phage assay results will be obtained. 349 
Conversely, if the MAP cells present are viable but non culturable at the point of testing, a 350 
positive PMS-phage assay result may be obtained that may or may not subsequently be 351 
backed up by a PMS-culture positive result.  During culture MAP cells will have the 352 
opportunity to recover full viability during the long incubation period, resulting in PMS-culture 353 
positives even though the corresponding PMS-phage assay result may have been negative. 354 
A second, more practical explanation for lack of agreement between the PMS-phage assay 355 
and PMS-culture results could be the fact that the bead sample after PMS was unequally 356 
split between the two detection methods. The majority (800 µl) of each 1 ml bead suspension 357 
after PMS was processed through the phage assay and only 200 µl was cultured. This may 358 
explain some of the discrepancies between the PMS-phage and PMS-culture results, 359 
particularly if milk samples containing low numbers of MAP were being testing.  Milk samples 360 
containing higher numbers of MAP would not have been so greatly impacted by the unequal 361 
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splitting of the milk sample, as these would likely still be positive for MAP in both fractions 362 
tested. Due to the finding of ‘poor’ agreement between results of the PMS-phage assay and 363 
PMS-culture, it was decided that it may be more appropriate to combine the test results when 364 
assessing diagnostic potential of the PMS-based assays.  Diagnostic sensitivity (DSe) 365 
increased from 0.250 (PMS-culture) and 0.325 (PMS-phage assay) to 0.525 when results of 366 
the two PMS-based tests were combined. DSp of the combined PMS-based methods was 367 
the same as PMS-culture (0.962), which was lower than for the PMS-phage assay (1.000).   368 
The DSp and DSe of the PMS-phage assay, PMS-culture, and the combined PMS-369 
based assays, were determined relative to the MAP infection status of the animals supplying 370 
the milk samples (Table 2).  There was a two year gap between faecal culture and serum-371 
ELISA testing of the animals in 2013, upon which each animal’s infection status was 372 
assigned, and the collection of milk samples for PMS-phage assay and PMS-culture testing 373 
in December 2015 and January 2016. This situation was not ideal, but was unavoidable 374 
given that regular Johne’s testing of cattle in these Northern Ireland dairy herds was not 375 
carried out. The infection status of the ‘MAP infected’ animals in Herds A and B from which 376 
milk was collected is unlikely to have changed in the intervening years (other than due to 377 
Johne’s disease progression), so estimates of DSe obtained for the PMS-based tests should 378 
still be reliable. For example, PMS-culture of milk demonstrated a DSe of 0.250, which is 379 
similar to that estimated for faecal culture (0.20) of Irish cattle by More et al. (2013); DSe of 380 
the PMS-phage assay and combined PMS-based tests were higher (0.325 and 0.525, 381 
respectively). The infection status of the animals in negative Herd C could have changed 382 
between 2013 and 2015/16. However, according to the animal health database of the 383 
Department of Agriculture, Environment and Rural Affairs for Northern Ireland, Herd C is still 384 
officially recorded as MAP ‘non-infected’ (Dr Lyanne McCallan, Agri-Food and Biosciences 385 
Institute for Northern Ireland, personal communication). PMS-culture results suggest there 386 
were four cows in negative Herd C that may have been MAP-infected at the time of milk 387 
collection in 2015/16.  Since these milk samples were PMS-culture positive, and not just 388 
PMS-phage assay positive, it seems rather unlikely they could be false positive results. The 389 
15 
 
detection of viable MAP in some milk samples from supposedly ‘non-infected’ animals 390 
reduced the DSp estimate from 1.000 for the PMS-phage assay to 0.962 for PMS-culture 391 
and for the combined use of the PMS-based tests (Table 2).   392 
 On the basis of the results of this study, the combined application of the PMS-phage 393 
assay and PMS-culture would appear to provide the most complete picture about MAP 394 
contamination of the milk of infected cows; DSp of the combined tests is high (0.962) and 395 
DSe is moderately high (0.525).  A properly designed validation study, testing milk samples 396 
contemporaneously with faeces and blood samples from the same animals, would be the 397 
next step in order to accurately assess the diagnostic potential of the novel PMS-based 398 
assays and their performance relative to the currently used diagnostic tests (faecal culture 399 
and serum-ELISA).   400 
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Table 1.  PMS-phage assay results for milk samples collected from MAP infected animals in 501 
Herds A and B. Only milk samples yielding plaques (pfu) are listed; all other milk samples 502 
tested negative by the PMS-phage assay.  503 
Herd ID Milk Sample 
ID 
Plaque count
(pfu/50 ml) 
IS900 Plaque-PCR
result* 
A 2ǂ 13 positive 
A 6 2 positive 
A 10ǂ 3 negative 
A 17 24 positive 
A 32ǂ 2 positive 
A 36 >300 positive 
A 37 4 positive 
A 44 >300 negative 
A 45 2 positive 
A 46 >300 positive 
A 47 >300 positive 
A 53 2 positive 
B 1 6 negative 
B 3 9 negative 
B 4 2 negative 
B 8 3 negative 
B 12 25 negative 
B 16 15 positive 
B 17 1 positive 
B 21 3 negative 
B 24 4 negative 
* Plaque PCR result dictated PMS-phage assay result - if the presence of MAP DNA was not 504 
confirmed the result was PMS-phage assay negative.   505 
ǂ Milk samples that subsequently tested PMS-culture positive, one of which had a negative 506 
PMS-phage assay result (Herd A, sample 10). 507 
 508 
 509 
 510 
 511 
 512 
 513 
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Table 2.  2 x 2 contingency tables comparing results of PMS-phage assay, PMS-culture and combined PMS methods with MAP infection status of 
cattle providing the milk samples tested. Kappa agreement and estimates of diagnostic sensitivity and specificity, determined using Fisher’s Exact 
Test, are presented for each of the tests.    
 
 
 
 
 
 
 
 
 
 
 
 
* Infection status of cow was assigned, prior to milk collection, based on results of faecal culture and serum-ELISA testing performed in 2013.   
ǂ The 40 ‘MAP infected’ cows were in Johne’s affected Herds A and B. The 105 ‘non-infected’ cows were exclusively in MAP negative Herd C.  
Test Test result Infection status* Kappa statistic  
± SE 
Diagnostic 
sensitivity 
(95% CI) 
Diagnostic 
specificity 
(95% CI) 
MAP infectedǂ 
(n=40) 
Non infectedǂ 
(n=105) 
PMS-phage assay Positive 13 0 0.411 ± 0.083 
(‘moderate’) 
0.325  
(0.186, 0.491) 
1.000  
(0.966, 1.000) 
 Negative 
 
27 105  
 
 
PMS-culture Positive 10 4 0.265 ± 0.084 
(‘fair’) 
0.250  
(0.127, 0.412) 
0.962 
(0.905, 0.989) 
 Negative 
 
30 101    
Combined PMS methods Positive 21 4 0.551 ± 0.080 
(‘moderate’) 
0.525  
(0.361, 0.685) 
0.962 
(0.905, 0.989) 
 
Negative 
 
19 101    
21 
 
 
 
 
Figure Legends 
 
Fig. 1. Venn diagram showing inter-relationships between results of the PMS-phage assay 
and PMS-culture applied to 145 bovine milk samples.  
 
